Extremity reconstruction devices are utilized to cure, rebuild, substitute, or heal fractures or damage to the extremities. Implant devices for the elbow, shoulder, wrist, fingers, foot, and ankle joints are included in the extremities reconstruction market size.

New York, July 01, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Extremity Reconstruction Market Size, Share & Industry Trends Analysis Report By Material, By Product, By Regional Outlook and Forecast, 2022 – 2028" - https://www.reportlinker.com/p06289243/?utm_source=GNW Outside articulated organs that perform various loco-motor functions are known as extremities. The human body is made up of four extremities: two lower limbs and two upper limbs. This surgery is used to correct flaws or deformities caused by trauma, cancer, and other medical problems. The procedures are important in improving the movement and appearance of damaged organs. Lower and Upper extremity operations are the two types of extremity surgery. Implants for the elbow, shoulder, ankle, wrist, and digits of the hands and feet are included in extremity reconstruction devices. It is because of the rising number of patients with malignancies, chronic diseases, and accidents that result in the amputation of limbs. This is becoming increasingly necessary for advancement in this sector to get more funding from the healthcare business. Plastic surgeons also utilize flaps or skin grafts to conceal wounds on the extremities, allowing patients to return to a more normal lifestyle more quickly. The market for extremities reconstruction devices is primarily driven by a rise in the number of joint disorders like rheumatoid arthritis and osteoarthritis, as well as a quick rise in lifestyle-related disorders such as diabetes and obesity, which lead to joint disorders. In addition, a rising focus on aesthetic views is expected to improve the market for extremities reconstruction technologies. Moreover, rising patient awareness of the advantages of small joint reconstruction implants, as well as improved technology like the advancement of reverse shoulder implants that require fewer ankle reconstruction implants and shoulder implants that help patients regain ankle mobility, are expected to boost the extremity reconstruction market. COVID-19 Impact Although it has been a substantial decline in non-cancer associated major reconstructive surgeries, a large amount of work for other types of surgeries continues to increase throughout lockdown. As well as in this period, increasing number of fatal accidents and injuries have been recorded, also many region governments in meantime is investing heavily to provide smooth healthcare facilities to the patients. As a result, the breakout of COVID-19 has a beneficial impact on the market for extremities reconstruction. The healthcare infrastructure has been working actively enough since the beginning of the COVID-19 pandemic and has been engaged all throughout this period. Market Growth Factors Surge in the number of plastic surgeries With an increase in instances noticed on a complete level, aesthetic medicine, cosmetic surgery, and minimally invasive procedures are reaching new heights. The leading countries for cosmetic surgery include many developed nations, which account for a significant portion of the comprehensive market for extremities tissue expanders. Such developed nation has appropriate healthcare infrastructure to assist the plastic surgery procedure. Also, people of these developed nations are financially sound enough to afford the costly cosmetic surgery. Increasing prevalence of natural attacks and calamities Mass casualty occurrences (MCIs), whether planned or unintentional, continue to be a serious problem for multidisciplinary trauma teams and emergency medical resources. Geographic disasters, such as earthquakes and landslides, regularly emphasize multi-national relief operations in resource-constrained situations. In an age of international and domestic terrorism, planned acts of mass violence involving explosives and firearms have shattered social closeness and put regional care centers to the test. The crush injuries to the lower and upper limbs, whose etiologies are based on the variety of disaster types, are of special concern in MCIs. Market Restraining Factors Risk factors for serious side effects Smoking has the potential to impair both circulation and healing. To decrease infection, nonunion, and wound healing issues, patients must abstain from smoking for at least few weeks before and after an electively planned operation. Patients who were existing smokers had a higher rate of infection, nonunion, and osteomyelitis in a prospective, multi-center investigation of limb trauma. It is because smoking cessation is often impossible following trauma, surgeons should continue with soft-tissue covering while encouraging postoperative cessation. The smokers and nonsmokers have similar rates of flap thrombosis after micro-surgical head and neck and breast reconstructions, however, the rate may be higher in individuals having lower extremity free flap reconstruction. Material Outlook Based on Material, the market is segmented into Metallic, Ceramic, Polymeric, and Natural. The ceramic material segment procured a substantial revenue share in the extremity reconstruction market in 2021. The ceramics had no negative biological effects. Tissue ingrowth into ceramic pores was observed in all three types and both pore diameters, however, the density of penetrating tissue was much lower in calcium aluminate than in tricalcium phosphate or calcium hydroxyapatite. The soft tissue ingrowth was denser with bigger pore sizes and longer implantation times for each kind of ceramic. In most cases, bone ingrowth was not visible inside the pores of any ceramic. The histology findings in the rats and rabbits were identical. Product Outlook Based on Product, the market is segmented into Upper Extremity and Lower Extremity. The upper extremity segment procured the highest revenue share in the extremity reconstruction market in 2021. Elbow reconstruction, Shoulder reconstruction, and wrist and hand reconstruction are the three types of upper extremity reconstruction devices. Ankle fusion, ankle reconstruction, and foot fusion are the three types of lower extremity reconstruction. It is because of the increasing number of patients choosing technological advances in shoulder implants, shoulder reconstruction surgery, and positive clinical outcomes of shoulder reconstruction surgeries. Stemless shoulder replacement is linked to less discomfort and blood loss, as well as a quicker recovery time. Regional Outlook Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America emerged as the leading region in the extremity reconstruction market in 2021. This is due to an increase in the prevalence of joint problems, as well as a rise in the older population. As an outcome, the region is on track to become one of the world’s oldest in the coming decades, due to abundant growth potential in terms of non-treated medical requirements for the treatment of minor joint problems, expanding awareness, and growing acceptance of new technologies. The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix; Johnson & Johnson is the forerunner in the Extremity Reconstruction Market. Companies such as Smith & Nephew plc, Stryker Corporation and Zimmer Biomet Holdings, Inc. are some of the key innovators in the Market. The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smith & Nephew PLC, Stryker Corporation, Zimmer Biomet Holdings, Inc., Johnson & Johnson (DePuy Synthes), Integra LifeSciences Holdings Corporation, Medtronic PLC, ConMed Corporation, Acumed LLC, Skeletal Dynamics, LLC, Arthrex, Inc., and IDS GeoRadar s.r.l.(Hexagon AB). Recent strategies deployed in Extremity Reconstruction Market Product Launch and Product Expansion: Mar-2022: Stryker introduced Insignia hip stem, a collared, hyaluronic acid-coated hip stem, utilized in total hip arthroplasty and hemiarthroplasty procedures. This product launch aimed to enable surgeons to improve patient outcomes. Feb-2022: Smith & Nephew expanded its product line of CORI surgical system, a handheld robotic surgery solution. This product expansion aimed to enable surgeons to use robotics for component alignment during THA procedures. In addition, RI. Hip Navigation on the CORI system would strengthen Smith & Nephew’s Real Intelligence digital ecosystem and underscores the commitment to advancing clinical outcomes in THA. Nov-2021: Depuy Synthes introduced UNIUM System as the newest inclusion to its Power Tools portfolio. This product launch aimed to offer surgeons an ergonomically advanced choice to give a high level of care. UNIUM System comprises two handpieces, a modular device, and a dedicated reciprocating saw, as well as a complete portfolio of attachments and cutting tools. Sep-2021: Stryker introduced T2 Alpha Femur Retrograde Nailing System, a new nailing solution. This product launch aimed to match surgeon preferences with enhanced ease of use during procedures. In addition, T2 Alpha Femur Retrograde Nailing System offers axial stability for surgeons via an advanced locking screw option built to restrict motion between the screw and nail, along with a guided, proximal targeting system created to lower the number of X-rays taken compared with freehand locking. Aug-2021: Depuy Synthes released the INHANCE Shoulder System, a first-to-market, fully unified shoulder arthroplasty system. This product launch is aimed at the INHANCE Shoulder System to align with how surgeons approach patient care. Jul-2020: Smith+Nephew unveiled the RI.HIP NAVIGATION, for purpose of total hip arthroplasty (THA). This product launch aimed to assist in maximizing precision and, reproducibility by providing patient-specific component alignment, an important factor for surgeons when checking indivIDUAL THA cases. In addition, RI.HIP NAVIGATION aid the surgeon take control of individual patient pelvic tilt, offset measurement, leg length, and support with cup placement by providing a predicted view of the post-op AP X-ray in surgery. Acquisition and Mergers: Feb-2022: Depuy Synthes took over CrossRoads Extremity Systems, a foot, and ankle company that provides a wide array of procedure-specific, instrumentation systems, and sterile-packed implants cleared for lower extremity indications, located in Tennessee. This acquisition aimed to improve meaningful innovation by strengthening the offering for elective foot and ankle procedures, allowing Depuy Synthes to provide more complete and leading-edge options to surgeons and patients. Dec-2021: Depuy Synthes completed the acquisition of OrthoSpin, a developer and manufacturer of automated strut systems, based in Israel. This acquisition aimed to help the patients to navigate the recovery with more confidence and less uncertainty with the strut adjustments. In addition, this acquisition would display the commitment of Depuy Synthes to bring transformative Medtech advancements to the industry via the application of automated technology that resolves a broad array of orthopedic challenges. Jan-2021: Integra LifeSciences took over ACell, a biotechnology company, based in Columbia, Maryland. This acquisition aimed to allow Integra LifeSciences to deliver more complete complex wound management solutions to resolve customers’ most pressing clinical challenges Jan-2021: Smith & Nephew took over the Extremity Orthopedics business of Integra LifeSciences Holdings. This acquisition aimed to assist Smith+Nephew’s strategy to invest in higher-growth segments. In addition, this acquisition would strengthen Smith+Nephew’s extremities business by including integration of emphasized sales channel, upper and lower extremities portfolio, complementary shoulder replacement, and a better new product pipeline. Dec-2020: Zimmer Biomet took over A&E Medical, a provider of a complete suite of sternal closure products. This acquisition aimed to enhance the standard of care and resolve a range of unmet patient and surgical requirements. In addition, this acquisition would benefit patients, surgeons, and health care systems. Nov-2020: Stryker took over Wright Medical Group, a global medical device company focused on Extremities and Biologics. This acquisition aimed to enhance the global market position in extremities and trauma, giving crucial opportunities to advance innovation and reach patients. Approvals and Trails: 2021-Apr: Zimmer Biomet received approval from FDA for ROSA Partial Knee System for the purpose of Robotically-Assisted Partial Knee Arthroplasty. This approval aimed to better bone cut precision and range of motion gap analysis, which may enhance flexion and restoration of natural joint movement. The ROSA Partial Knee System is the newest inclusion to ROSA Robotics, Zimmer Biomet’s multiple application robotics platform which comprises the ROSA Knee System for total knee replacement surgery and ROSA ONE for neurosurgical and spine procedures. The ROSA Partial Knee System features proprietary 2D to 3D X-Atlas imaging technology and real-time, intraoperative data gathering on soft tissue and bone anatomy. Scope of the Study Market Segments covered in the Report: By Material • Metallic • Ceramic • Polymeric • Natural By Product • Upper Extremity • Lower Extremity By Geography • North America o US o Canada o Mexico o Rest of North America • Europe o Germany o UK o France o Russia o Spain o Italy o Rest of Europe • Asia Pacific o China o Japan o India o South Korea o Singapore o Malaysia o Rest of Asia Pacific • LAMEA o Brazil o Argentina o UAE o Saudi Arabia o South Africa o Nigeria o Rest of LAMEA Companies Profiled • Smith & Nephew PLC • Stryker Corporation • Zimmer Biomet Holdings, Inc. • Johnson & Johnson (DePuy Synthes) • Integra LifeSciences Holdings Corporation • Medtronic PLC • ConMed Corporation • Acumed LLC • Skeletal Dynamics, LLC • Arthrex, Inc Unique Offerings • Exhaustive coverage • Highest number of market tables and figures • Subscription based model available • Guaranteed best price • Assured post sales research support with 10% customization free Read the full report: https://www.reportlinker.com/p06289243/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________

The U.S. is gearing up for another wave of COVID-19 infections in the fall and winter following a flurry of activity this week.

The meal kit startup says at least 470 people have reported illnesses so far.

Achieving classical herd immunity against SARS-CoV-2 is "unlikely" despite the effectiveness of vaccines, according to health experts. Herd immunity refers to how much of the population needs to be vaccinated or infected with COVID-19 in order to "eradicate or eliminate" the disease. The country's top infectious disease expert Dr. Anthony Fauci spoke about herd immunity during an interview with KCRA 3 and the National Press Foundation.

Is Johnson & Johnson stock a buy after the company unveiled positive results in cancer treatment this month? Is JNJ stock a buy?

The move that comes amid growing calls for tech companies to ramp up privacy controls in the wake of last week’s Supreme Court decision to eliminate the constitutional right to an abortion.

Google says it will remove abortion clinics and other facilities from users’ location history amid renewed concerns about data privacy following the Supreme Court’s decision to overturn Roe v. Wade.

Approximately 100 million Americans have nonalcoholic fatty liver disease, according to the American Liver Foundation. "Fatty liver disease in fact is on the rise," says Jamile Wakim-Fleming, MD, Director of Cleveland Clinic's Fatty Liver Disease Program. "When I first joined the Cleveland Clinic 2002, we were busy dealing with hepatitis C. Fatty liver was barely talked about. In the last 15 years, we have found a cure for hepatitis C so we don't see it as much. Now, we see more of fatty liver d

Viruses evolve, and vaccines should too. That was the big-picture takeaway from a pivotal meeting this week of the FDA’s expert advisory panel. The question before them was simple: Ahead of an expected winter surge, should vaccine manufacturers tweak their forthcoming booster shots to target Omicron, or should they stick with the tried-and-true 2020 recipe?

Let’s talk about bowel movements . We all pass ‘em, but some of us more than others, which got us wondering what’s normal. So, how often should you poop? We...

The infectious-disease expert was feeling "really poorly" and began a second round of Paxlovid.

Photo Illustration by The Daily Beast / GettyStock up on the Metamucil, folks. Scientists say you need to start saving your poop.A team of researchers at ​​Harvard Medical School and Brigham and Women’s Hospital published an opinion article in the journal Trends in Molecular Medicine today sounding the alarm on a trend in how human gut microbiomes (microorganisms in your digestive tract like bacteria) have changed in the past decades. These changes have been connected to an increase in digestive

Nike, Starbucks, Lyft, JPMorgan Chase and more are offering benefits, including travel reimbursements, for employees in states where abortion would be illegal after the Supreme Court's ruling to overturn Roe v. Wade.

Gut health is important for so many reasons! First of all, when the gut is unhealthy it can lead to a variety of digestive symptoms such as heartburn, abdominal pain, bloating, excess gas, constipation, and diarrhea, just to name a few. These symptoms can be very disruptive to daily life and can get in the way of work, school, relationships, and even enjoying a normal meal. Another reason it's important to have a healthy gut is that the gut is connected to so many other body systems. For this re

Nearly two dozen people have been sickened with listeria, and one has died, according to the Centers for Disease Control and Prevention, which said the source of the outbreak has not been identified.

Insurance companies must now post their negotiated rates for doctors, hospitals, and more.

Pfizer Inc (NYSE: PFE) has submitted a new drug application to the FDA for the approval of Paxlovid for patients at high risk for progression to severe illness from COVID-19. Paxlovid is currently authorized for emergency use to treat mild-to-moderate COVID-19 in adults and pediatric patients at high risk for progression to severe COVID-19, including hospitalization or death. The submission provides the longer-term follow-up data necessary for acceptance and potential approval. Related: Pfizer H

U.S. regulators are telling COVID-19 vaccine makers to tweak any booster doses intended for fall so they protect against the newest omicron relatives

We know that when it comes to health, prevention is better than cure—but what if you're undermining your wellbeing without knowing it? "I often see patients who feel they are doing everything right. They are eating nutrient-dense foods, getting adequate sleep, going to the gym…but they just don't feel good," says Mark Hyman, MD. Here are five ways you might be seriously harming your health. Read on—and to ensure your health and the health of others, don't miss these Sure Signs You've Already Had

"As the Covid pandemic continues to evolve and be highly unpredictable, we must remain vigilant in protecting those who are at greatest risk of getting very sick from Covid," said CEO Albert Bourla.

Fighting with family and friends about the SCOTUS decision can feel hopeless. Here’s how to be heard while staying sane.